These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 16398909

  • 1. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Kay GG, Abou-Donia MB, Messer WS, Murphy DG, Tsao JW, Ouslander JG.
    J Am Geriatr Soc; 2005 Dec; 53(12):2195-201. PubMed ID: 16398909
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Dec; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
    Staskin D, Kay G, Tannenbaum C, Goldman HB, Bhashi K, Ling J, Oefelein MG.
    Int J Clin Pract; 2010 Aug; 64(9):1294-300. PubMed ID: 20561092
    [Abstract] [Full Text] [Related]

  • 13. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
    Hegde SS, Mammen M, Jasper JR.
    Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
    [Abstract] [Full Text] [Related]

  • 14. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A.
    Clin Neuropharmacol; 2006 Jan; 29(4):220-9. PubMed ID: 16855424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
    Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ.
    Br J Pharmacol; 2006 Jul; 148(5):565-78. PubMed ID: 16751797
    [Abstract] [Full Text] [Related]

  • 20. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?
    Finney SM, Andersson KE, Gillespie JI, Stewart LH.
    BJU Int; 2006 Sep; 98(3):503-7. PubMed ID: 16925744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.